Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Amigorena

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
Nature Medicine|March 7, 2001
Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-primingJ Wolfers, A Lozier, G Raposo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 7, 2000
The B subunit of Shiga toxin fused to a tumor antigen elicits CTL and targets dendritic cells to allow MHC class I-restricted presentation of peptides derived from exogenous antigensN Haicheur, E Bismuth, S Bosset, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 16, 2014
Autologous dendritic cells prolong allograft survival through Tmem176b-dependent antigen cross-presentationM Segovia, C Louvet, P Charnet, et al.
Oncogene|October 20, 2010
Milk fat globule--epidermal growth factor--factor VIII (MFGE8)/lactadherin promotes bladder tumor developmentG Sugano, I Bernard-Pierrot, M Laé, et al.
Immunity|March 26, 2002
FcgammaRI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infectionA Ioan-Facsinay, S J de Kimpe, S M M Hellwig, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
Nature Medicine|March 7, 2001
Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-primingJ Wolfers, A Lozier, G Raposo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 7, 2000
The B subunit of Shiga toxin fused to a tumor antigen elicits CTL and targets dendritic cells to allow MHC class I-restricted presentation of peptides derived from exogenous antigensN Haicheur, E Bismuth, S Bosset, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 16, 2014
Autologous dendritic cells prolong allograft survival through Tmem176b-dependent antigen cross-presentationM Segovia, C Louvet, P Charnet, et al.
Oncogene|October 20, 2010
Milk fat globule--epidermal growth factor--factor VIII (MFGE8)/lactadherin promotes bladder tumor developmentG Sugano, I Bernard-Pierrot, M Laé, et al.
Immunity|March 26, 2002
FcgammaRI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infectionA Ioan-Facsinay, S J de Kimpe, S M M Hellwig, et al.
Pageof 7